GERD LUIPPOLD,MICHAEL MARK,ODD-ERIK JOHANSEN,ROLF GREMPLER,THOMAS KLEIN
申请号：
BR112013011968
公开号：
BR112013011968A2
申请日:
2011.11.07
申请国别(地区):
BR
年份:
2016
代理人:
摘要：
The invention relates to a pharmaceutical composition according to the claim 1 comprising an SGLT2 inhibitor and an insulin which is suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions
